Campbell & Co Investment Adviser’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
Campbell & Co Investment Adviser's ATEX Position: Q2 2026 in Review
Campbell & Co Investment Adviser reduced its Anterix (ATEX) stake by 48% in Q2 2026, selling an estimated $1.14M and leaving 21,084 shares worth $2.17M. The position accounts for 0.11% of the portfolio, ranked #296.
Campbell & Co Investment Adviser first reported a position in ATEX in Q2 2025 and has held it in 5 quarters since. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- Campbell & Co Investment Adviser held 21,084 shares of Anterix worth $2.17M as of Q2 2026.
- Campbell & Co Investment Adviser sold 19,376 Anterix shares in Q2 2026, an estimated $1.14M.
- Anterix made up 0.11% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #296 holding.
- Campbell & Co Investment Adviser first reported a position in Anterix in Q2 2025 and has held it in 5 quarters since.
- 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.